3 are located in the germinal centers (GCs) of secondary lymphoid tissues where they trap and retain Ags in the form of immune complexes (1, 2). FDC-trapped Ags persist for many months in an unprocessed form and maintain long term, memory IgG and IgE responses to soluble protein Ags (1, 3-7). FDCs also provide Agindependent signals to T and B lymphocytes that alter their state of activation/proliferation and render B cells responsive to chemoattractants (8 -10). Thus, in normal physiology, FDCs are important to the GC reaction that generates and maintains T-dependent humoral immune responses.
F ollicular dendritic cells (FDCs) 3 are located in the germinal centers (GCs) of secondary lymphoid tissues where they trap and retain Ags in the form of immune complexes (1, 2) . FDC-trapped Ags persist for many months in an unprocessed form and maintain long term, memory IgG and IgE responses to soluble protein Ags (1, (3) (4) (5) (6) (7) . FDCs also provide Agindependent signals to T and B lymphocytes that alter their state of activation/proliferation and render B cells responsive to chemoattractants (8 -10) . Thus, in normal physiology, FDCs are important to the GC reaction that generates and maintains T-dependent humoral immune responses.
Early after infection with HIV, the secondary lymphoid tissue becomes a major reservoir of virus with the vast majority of HIV particles found on the surface of FDCs (estimated to be 1.5 ϫ 10 8 copies of viral RNA per gram of lymphoid tissue) (11) (12) (13) . Importantly, HIV immune complexes on FDCs are highly infectious even in the presence of high levels of neutralizing Ab (14) . Our recent studies have indicated that FDCs maintain HIV infectivity in vivo for many months in the complete absence of viral infection and/or replication (15) . Additionally, FDCs appear to increase the production of virus in CD4 lymphocytes (16) . Thus, secondary lymphoid tissues, in particular the GC microenvironment, bring together a reservoir of trapped, infectious virus on FDCs, CD4-bearing target cells, and an environment of high cellular activation creating an ideal site for HIV infection. The importance of this microenvironment is underscored by the observation that in asymptomatic HIV-infected subjects, the lymphoid follicles are the primary site of active viral infection (17) (18) (19) (20) .
HIV-1 infection of target cells requires the presence of both the CD4 receptor and a chemokine coreceptor. Two chemokine receptors serve as major coreceptors for HIV: CCR5 binds HIV-1 R5 virus; whereas CXCR4 binds HIV-1 X4 isolates (21) (22) (23) (24) (25) (26) . T lymphocytes and macrophages in both lymphoid and nonlymphoid tissues are the major cell populations expressing HIV coreceptors. In lymph nodes, CXCR4-bearing cells are found almost exclusively inside GCs and in the medulla, whereas CCR5-bearing cells exist primarily in the medulla and extrafollicular areas of the cortex (27) . Thus, HIV coreceptor expression appears to be differentially regulated within secondary lymphoid tissues with a major population of CXCR4-bearing target cells surrounding the FDC reservoir of infectious virus.
HIV-1 coreceptor density also appears to play an important role in HIV-1 infection. Individuals who are heterozygous for the ⌬32-ccr5 polymorphism have decreased CCR5 expression and slower progression of HIV disease (28, 29) . CXCR4 expression also affects viral entry as evidenced by the observation that slight increases in CXCR4 expression, arising from CD28 signaling or from HIV-1 Tat expression, lead to increased viral entry by the X4 molecular clone, HXB2 (30, 31) . Because HIV coreceptor density appears to be important in HIV infection and disease progression, we reasoned that the predominance of CXCR4 in GCs might contribute to transmission of infection in these sites. Because FDCs are unique to lymphoid follicles and are juxtaposed to CD4 T cells expressing CXCR4, we sought to determine whether FDCs contributed to the expression of this HIV coreceptor on CD4 T cells and thus to viral pathogenesis. We report here that FDCs up-regulated CXCR4 on CD4 T lymphocytes although having little effect on CD4 or CCR5 expression. Furthermore, we found that increased CXCR4 expression on CD4 T cells augmented HIV-1 X4, but not R5, virus binding and entry. Finally, we observed that freshly isolated CD4 ϩ CD57 ϩ GC T cells also expressed high levels of CXCR4 and were readily infected by doses of HIV that did not appear to infect other CD4 T cells with lower CXCR4 expression. Collectively, these data indicate that FDCs increase CXCR4 expression on CD4 T cells and that this increase may make GC T cells especially susceptible to HIV infection as well as potentially contributing to virus tropism changes that occur in many infected subjects.
Materials and Methods

Flow cytometric analysis
Cell surface Ags were detected using the following mAbs: anti-human CD3-PE and PC5 (UCHT1), anti-human CD4-PC5 (13B8.2), anti-human CD45RO-PE (UCHL1), anti-human CD57-FITC or biotin (NC1), and anti-CD69-PE (TP1.55.3) (Immunotech, Westbrook, ME); anti-human CCR5-FITC (2D7), anti-human CXCR4-PE (12G5) (BD PharMingen, San Diego, CA); mouse IgM anti-human FDC (HJ2) (gift from Dr. M. Nahm, University of Alabama, Birmingham, AL); and donkey, F(abЈ) 2 anti-mouse IgM-FITC (Jackson ImmunoResearch Laboratories, West Grove, PA). Mouse isotype-matched control IgG1 (679.1 Mc7) and IgG2a (U7.27) (Immunotech) were also used. Cells were incubated for 30 min on ice first with Fc-blocking reagent (Miltenyi Biotec, Auburn, CA) and then with specific mAbs. Cells were then washed in PBS, and 10,000 CD4 T cells were analyzed using an EPICS XL flow cytometer with EXPO32 ADC software (Beckman Coulter, Fullerton, CA) for immunofluorescence analysis. Positive gating was established using mouse isotype-matched control Abs to define background fluorescence. Propidium iodide (PI) (0.5 g; SigmaAldrich, St. Louis, MO) labeling was used to exclude dead cells. Quantitation of Ab-binding sites (ABS) was performed using Quantum Simply Cellular Microbeads (Sigma-Aldrich) per the manufacturer's instructions and as previously described (32) .
FDC isolation
Human FDCs were isolated from tonsillar tissue as described (15) . FDCenriched preparations prepared by this procedure were examined by flow cytometry and typically contain 75-90% FDCs with residual cells consisting of T and B lymphocytes. Because FDCs are resistant to radiation, the preparations are subjected to 3000 rad of gamma-irradiation to inhibit the ability of contaminating lymphocytes to support HIV infection. The function of the FDCs was confirmed by their ability to provide costimulation to lymphocytes as previously described (9) . In all experiments, an FDC:CD4 T cell ratio of 1:10 was used because we found this to result in optimal FDC-lymphocyte interactions. In some experiments, FDCs were specifically depleted by collecting the effluent from the MACS columns used to positively select FDCs, and these cells were then subjected to a further round of FDC depletion using HJ2 and magnetic beads (rat anti-mouse IgM Dyna-beads; Dynal Biotech, Great Neck, NY) at a concentration of 10 beads per target cell. This treatment removed Ն90% of the FDCs (9).
T cell preparations
Human PBLs were isolated from whole blood using Ficoll-Paque (Amersham Pharmacia Biotech, Piscataway, NJ), and CD4 T lymphocytes were enriched by negative selection using a CD4 ϩ T cell isolation kit (Miltenyi Biotec). The resulting preparations were Ն95% CD4 T cells as assessed by flow cytometry. Human tonsillar CD4 T cells were purified after mechanical tissue homogenization or after enzymatic digestion of the tonsillar tissue used for FDC isolations. Isolated cells were then centrifuged (700 ϫ g for 25 min) on preformed, 50% continuous Percoll gradients. T cells were then obtained from two fractions: the low density layer (1.050 -1.060 g/ml), which also contains the FDCs and activated lymphocytes; and the high density layer (1.074 -1.087 g/ml) which contains predominantly resting T cells. For CD4 ϩ CD57 ϩ GC T cell isolation, human tonsillar tissue were cut into small sections and cells mechanically separated from tissue by repeat pipeting. RBCs were removed from the lymphocytes by lysis in RBC lysis buffer (155 mM NH 4 Cl, 10 mM KHCO 3 , and 0.1 mM EDTA) for 5 min at room temperature. CD4 T lymphocytes were enriched by negative selection using a CD4 ϩ T cell isolation kit (Miltenyi Biotec) followed by positive selection using anti-CD57-biotin and streptavidin microbeads by MACS (Miltenyi Biotec). The resulting CD4 ϩ CD57 ϩ preparations were Ն92% pure as assessed by flow cytometry. 125 I surface labeled HIV-1 IIIB having a specific activity of 0.5 Ci/g (6.8 ϫ 10 7 viral particles) for 2 h on ice, washed three times to remove unbound virus, and bound virus quantitated using a gamma counter. For nonradiolabeled HIV binding experiments, cells with differential CXCR4 expression were incubated with HIV blocking anti-CD4 Ab, SIM-4 (100 l hybridoma supernatant; National Institutes of Health AIDS Research and Reference Reagent Program, Bethesda, MD), stromal cell-derived factor-1␣ (SDF-1␣ (2.5 g; Upstate Biotechnology, Lake Placid, NY), macrophage-inhibitory protein-1␤ (MIP-1␤) (2.5 g; National Institutes of Health AIDS Research and Reference Reagent Program) or medium alone for 30 min on ice. Primary HIV-1 isolates 91US054 (X4) or 92US714 (R5) (National Institutes of Health AIDS Research and Reference Reagent Program) were then incubated with these cells at the indicated concentrations for 2 h on ice. Cells were washed extensively, and surface HIV was detected by measuring HIV gag p24 protein by ELISA according to the manufacturer's instructions (Beckman Coulter). For HIV entry assays, cells with differential CXCR4 expression were incubated at 37°C with HIV-1 IIIB at the indicated concentrations for 1 h, washed, and treated with trypsin (0.5% v/v; HyClone) for 20 min at 37°C to remove surface-bound virus. Cells were washed three times, and HIV entry was assessed by detection of intracellular HIV gag p24 by ELISA. In addition, HIV entry was performed by detection of reverse transcribed HIV gag products using DNA-PCR. In some experiments testing the specificity of the receptors involved, CD4 T cells (1 ϫ 10 5 ) expressing differential CXCR4 expression or CD4 T cells (2.5 ϫ 10 5 ) cultured with or without FDCs (2.5 ϫ 10 4 ) were incubated with anti-CXCR4 mAb 12G5 (10 g; BD PharMingen), anti-CCR5 mAb 2D7 (10 g; BD PharMingen), SDF-1␣ (2.5 g), or MIP-1␤ (2.5 g) or alone for 30 min on ice. These cells were incubated with HIV-1 IIIB or X4 primary strain 91US054 for 1 h, washed three times, and incubated for an additional 12-13 h to allow reverse transcription to occur. Cells were washed three more times in PBS, lysed using 50 l DNA lysis buffer (0.01% SDS, 0.001% Triton X-100, 0.42 g/ml proteinase K in TE (10 mM THAM (Fisher, Pittsburgh, PA) and 1 mM EDTA). Cell lysis and protein digestion were performed at 55°C for 5 h, and the resulting DNA-containing cell lysate was simultaneously PCR amplified for both HIV gag and cellular ␤-globin. PCR contained RNase-DNase-free M each of ␤-globin-GH20/PC04 primers (34) . Thirty cycles of DNA-PCR amplification were performed in a PTC-100 thermal cycler (MJ Research, Cambridge, MA) as follows: 94°C for 2 min, 55°C for 30 s, 72°C for 2 min; the initial cycle began with an additional 3-min denaturation step (94°C) and after the final cycle, an additional extension was performed for 10 min at 72°C). Amplicons were resolved on a 2% agarose gel by electrophoresis and transferred to HyBond-N ϩ nylon transfer membrane (Amersham Pharmacia Biotech), and Southern blot was performed using the HIV-1 gag-SK19 probe (33) with the ECL detection system (Amersham Pharmacia Biotech).
FDC-CD4 T cell cocultures
Immunohistochemistry
CD4
ϩ T cells in the GCs were characterized on frozen tonsil sections by two-color immunofluorescence. The sections were incubated with Abs Leu3a (CD4 IgG1; BD Biosciences, San Jose, CA) and Leu7 (CD57; BD Biosciences) for 45 min. The sections were rinsed in PBS and fixed in 4% (w/v) paraformaldehyde for 20 min. After a rinsing in PBS, goat antimouse IgG1-FITC (Southern Biotechnology Associates, Birmingham, AL) and then Alexa Fluor 488 conjugate (Molecular Probes, Eugene, OR) were applied for 30 min each. To visualize the binding of the CD57 mAb, the sections were incubated with an isotype-matched, biotin-conjugated secondary Ab (Dianova, Hamburg, Germany) and tetramethylrhodamine isothiocyanate-conjugated streptavidin (Jackson ImmunoResearch Laboratories). The sections were rinsed in PBS and examined by fluorescent microscopy.
Results
FDC effects on CXCR4, CCR5 and CD4 expression on CD4 T cells
To begin to determine the ability of FDCs to affect HIV receptor expression on CD4 lymphocytes, we cultured resting CD4 ϩ T cells with or without FDCs and examined CD4R, CCR5R, and CXCR4R expression after 24 and 72 h using quantitative flow cytometry (Fig. 1) . FDCs had little effect on either CD4 or CCR5 expressed on T cells but increased the expression of CXCR4 at both the 24-and 72-h time intervals. Because FDCs did not appear to alter the expression of CD4 or CCR5 on T cells, we focused our efforts on CXCR4 and sought to establish the kinetics of FDC up-regulation of this receptor ( Fig. 2A) . Expression of CXCR4 on CD4 T cells cultured without FDCs increased during the first 24 h, as has been reported previously (35) ; however, this expression decreased thereafter whereas the presence of FDCs resulted in a rapid and sustained increase in CXCR4 expression. Examination of CD69 and CD25 activation markers failed to demonstrate any differences in cells incubated with or without FDCs. Because CXCR4 is found both at the cell surface and in intracellular stores (36), we examined intracellular CXCR4 in CD4 T cells and observed that the addition of FDCs had little effect on internal CXCR4 expression even though the surface expression of this receptor was increased over the same time period (data not shown). In addition to resting CD4 ϩ T cells, FDCs increased CXCR4 receptor expression on stimulated (i.e., PHA, anti-CD3, anti-CD3/ CD28, or IL-2) CD4 ϩ lymphocytes with kinetics similar to resting CD4 ϩ T cells (data not shown). Because our FDC-enriched preparations typically contain ϳ75-90% FDCs, with the remainder of the cells being lymphocytes, we sought to confirm that FDCs, and not residual T and B cells, mediated the observed increases in CD4 T cell expression of CXCR4. To test this, control tonsillar cell preparations specifically depleted of FDCs were cultured with CD4 T cells to determine their ability to increase CXCR4 expression ( Fig. 2A, OE) . Cells depleted of FDCs had no ability to increase extracellular (or intracellular, data not shown) expression of CXCR4, thus indicating that FDCs and not other tonsillar cells were needed to induce CXCR4 up-regulation. Because CD4 ϩ T cells cultured without FDCs demonstrated an initial rise in CXCR4 expression followed by a decrease by day 3 (see Fig. 2A, F) , we next sought to determine whether FDCs could increase CXCR4 expression on these cells (i.e., that had recently down-regulated this receptor). We therefore cultured CD4 T cells for 3 days followed by an additional incubation with or without FDCs for 1 day and monitored CXCR4 expression (Fig. 2B ). The addition of FDCs to these previously cultured T cells resulted in an increase of both the percentage of CD4 ϩ T cells that expressed CXCR4 (from 14% to 72%) and the receptor density per cell (Ͼ200% increase). Thus, not only did FDCs increase CXCR4 expression on freshly isolated cells but also rescued expression on cells that had recently downregulated this receptor.
Because FDCs up-regulated CXCR4 expression on CD4 T cells, we next sought to establish the nature of the signal provided by FDCs. To determine whether an FDC-secreted soluble factor was responsible for CXCR4 up-regulation, we separated CD4 T cells from FDCs using a Transwell culture system (Fig. 2C) . As before, FDCs up-regulated CXCR4 when cocultured directly with CD4 T cells; however, when FDCs were separated from CD4 T cells, CXCR4 up-regulation was abrogated. To further establish that a soluble factor was not necessary for CXCR4 up-regulation, we cultured CD4 T cells with paraformaldehyde-fixed FDCs and assessed CXCR4 expression after 24 h (Fig. 2C) . Fixed FDCs were able to up-regulate CXCR4 on CD4 T cells as well as viable,
Increased CXCR4 expression directly correlates with augmented HIV-1 binding and entry
Because FDCs increased CXCR4 expression on CD4 T cells, we sought to determine whether these cells demonstrated an increased susceptibility to HIV infection. To initially address this question, we examined the level of virus binding and subsequent entry into lymphocytes that expressed different levels of CXCR4 in a simplified system without FDCs. Because lymphocytes were found to increase their CXCR4 expression during the first 24 h of culture ( Fig. 2A, F high cells, respectively). We reasoned that if X4 virus binding depended primarily on HIV gp120-CD4/CXCR4 interactions, then virus isolates using CCR5 as a coreceptor would not demonstrate differential binding to the same cells. At the same time, we sought to confirm our results using radiolabeled virus with a procedure that did not require manipulation of the HIV surface. CD4 T cells with high or low CXCR4 expression were incubated with an R5 or X4 primary isolate of HIV-1, and surface-bound virus was assessed by quantitation of HIV-1 p24 (Fig. 3, A and B) . As expected, only the binding of the X4 primary isolate correlated with the different amounts of CXCR4 expressed on the target cells. Furthermore, the addition of specific ligand for CXCR4 and CCR5 inhibited virus binding by the corresponding X4 and R5 virus, respectively. Thus, these data indicate that relatively small differences in cell surface expression of CXCR4 can have a strong effect on the amount of X4 tropic HIV-1 that associates with primary CD4 T cells. To determine whether increased binding of X4 virus led to increased entry, CD4 T cells expressing differential levels of CXCR4 were exposed to HIV-1 IIIB or primary X4 HIV-1 and assessed for virus entry by DNA PCR amplification of the HIV gag gene (Fig.  3C) . When entry using HIV IIIB was assessed, the signal obtained appeared much stronger in CXCR4 high cells than in CXCR4 low cells. Furthermore, when the HIV-1-binding sites of CXCR4 were inhibited by the addition of specific Ab (12G5) to CXCR4 high cells, the intensity of the hybridization signal for the gag amplicon was reduced to a level similar to that obtained using CXCR4 low CD4 T cells. In contrast to the results obtained with the CXCR4-specific Ab, no change was visualized when cells were treated with a CCR5-inhibiting Ab (2D7). Strikingly, HIV entry was much more robust in CXCR4 high cells than in CXCR4 low cells when a primary X4 strain of HIV-1 was used (Fig. 3C ). The addition of either blocking CXCR4 Ab (12G5) or ligand (SDF-1␣) inhibited virus entry into CXCR4 high cells, whereas the addition of blocking CCR5 Ab (2D7) or ligand (MIP-1␤) had no effect. Finally, CD4 T cells were also examined for virus entry by measuring intracellular p24, which confirmed the PCR-based entry assays (Fig. 3D) . These data were consistent with the hypothesis that HIV binding and entry were in large part dependent on CXCR4 expression levels. Because our previous experiments assessing virus entry were performed in a simplified system where lymphocytes were induced to express CXCR4 in the absence of FDCs, we next sought to confirm that T cells cultured with FDCs also resulted in increased virus entry. CD4 T cells that had been incubated with or without FDCs for 1, 2, or 3 days ( Fig. 2A) were exposed to HIV-1 IIIB, after which viral entry was assessed by DNA PCR (Fig. 4) . At the concentration of virus used, HIV-1 gag was detected only in CD4 T cells that were cocultured with FDCs, indicating that FDC-mediated increases in CXCR4 expression correlated with increased virus entry.
GC T cells express high levels of CXCR4 and are highly susceptible to HIV entry
We reasoned that if FDCs contributed to HIV pathogenesis by increasing CD4 T cell expression of CXCR4 in vivo, then CD4 T cells surrounding FDCs within GCs of secondary lymphoid tissues should express high levels of CXCR4 and be more susceptible to virus entry than other CD4 T cells. To begin to test this hypothesis, we first sought to obtain GC CD4 T cells from tonsillar tissue. It has been reported that many GC T cells are CD4 ϩ CD45RO ϩ and that a majority also express CD57 (37) (38) (39) (40) (41) . To determine whether isolation of CD4 ϩ CD57 ϩ cells would represent true GC T cells, immunohistochemical analysis of tonsillar tissue was performed (Fig. 5) . In agreement with previous data, CD4 ϩ CD57 ϩ T cells were found exclusively in GCs and localized in the light zone of these structures, the same area in which FDCs reside. Depending on the plane of sectioning, 42-69% of the GC CD4 ϩ T cells were CD57 ϩ . A few CD57
ϩ lymphocytes were present in the extrafollicular lymphoid tissue, but they did not coexpress the CD4 Ag. To further characterize GC T cells, tonsillar CD4 ϩ CD57 ϩ T cells were isolated and analyzed for both CD45RO and CD69 expression (Fig. 6, A and B) . Consistent with previous reports, virtually all CD4 ϩ CD57 ϩ GC T cells coexpressed both CD45RO and the early activation Ag CD69. Because CD4 ϩ CD57 ϩ cells represented GC T cells, we examined these cells for CXCR4 expression (Fig. 6C) . In six separate experiments, freshly isolated CD4 ϩ CD57 ϩ T cells had higher CXCR4 expression (mean, 13,040 Ϯ 3,528 ABS) than CD4 ϩ CD57 Ϫ T cells (mean, 3,525 Ϯ 1,029 ABS) from the same donor while at the same time expressing similar levels of CD4 (data not shown). Lastly, we sought to assess the susceptibility of GC CD4 T cells to HIV-1 entry compared with other CD4 T cells from the same tissue (Fig. 7) . GC T cells appeared more susceptible to infection by HIV-1; this was particularly evident as the concentration of virus decreased. Thus, not only did FDCs increase CXCR4 expression on CD4 T cells in vitro but also T cells in GCs surrounding FDCs in vivo expressed higher levels of CXCR4 and demonstrated a corresponding increased susceptibility to infection ex vivo.
Discussion
Throughout the course of disease, active HIV infection is found primarily in the lymphoid follicles of secondary lymphoid tissues where FDCs reside (12, 17-20, 42, 43) . Our previous work indicated that the microenvironment surrounding FDCs is ideally suited for the transmission of HIV infection because these 4 cpm reverse transcriptase activity) for 1 h at 37°C. Cells were washed three times to remove unbound virus and incubated for an additional 12-13 h to allow reverse transcription to occur. Following incubation, DNA-containing cell lysates were PCR amplified for both HIV gag and cellular ␤-globin genes. The amount of virus used in this experiment is reduced 4-fold from that used in Fig. 3D ; with this lower concentration, only the cells expressing Hi CXCR4 demonstrated HIV DNA. ACH-2 cells (5 ϫ 10 4 ), which contain one copy of the HIV-1 genome per cell, were used as a positive control.
FIGURE 5. GC CD4
ϩ T cells express the CD57 Ag. Tonsillar sections from an HIV-seronegative individual showing CD4 ϩ T cells (green) in the light zone of a GC. The CD57 Ag (red) is coexpressed on a subset of CD4 ϩ lymphocytes (yellow) in these sites. Original magnification, ϫ100.
cells maintain the virus in an infectious form for months in the absence of active infection and/or replication and can permit infection even in the presence of high levels of neutralizing Ab (14 -16) . In this study, we focused on expanding our understanding of FDC contributions to HIV pathogenesis. Specifically, we sought to determine whether FDCs altered the expression of receptors on CD4 T cells needed for HIV infection. We found that the presence of FDCs in cocultures led to increased expression of CXCR4 on CD4 T cells but had little effect on CCR5 or CD4 and that FDC-CD4 T cell contact was important for this observed CXCR4 up-regulation. Attachment of HIV to the surface of certain cell lines may occur through non-HIV receptor interactions (44) ; however, our data indicated that increased CXCR4 expression augmented both virus binding and entry by X4 (both laboratory and primary strains) but not primary R5 isolates of HIV-1 in CD4 T cells, suggesting that HIV coreceptor expression is a major factor in both HIV attachment and entry into primary lymphocytes. Importantly, examination of freshly isolated GC T cells that expressed the CD4 ϩ CD57 ϩ CD45RO ϩ phenotype revealed higher CXCR4 expression than other CD4 lymphocytes and indicated that these cells were more susceptible to infection by X4 HIV-1 isolates.
Our observation that FDCs increased CXCR4 expression, virus binding, and subsequent entry into CD4 lymphocytes supports the hypothesis that the microenvironment of the GC is highly conducive to HIV infection and that CXCR4 high expressing CD57 ϩ GC T cells may be particularly susceptible targets for this virus. Our findings add to those of Hufert et al. (45) , who observed that CD57 ϩ GC T cells were more susceptible than other cells to HIV infection by providing a potential mechanism for the increased receptor expression and showing that this correlated with susceptibility to infection. In this latter context, we also observed that increased CXCR4 became particularly important as the concentration of HIV was decreased, suggesting that as virus levels decrease in vivo, as would occur in subjects treated with current potent drug therapies, GC T cells with increased CXCR4 expression may be especially important targets for HIV. Our findings also strongly support the concept that relatively small differences in CXCR4 expression on primary target cells can have important consequences to HIV infection and suggest that in addition to serving as an important reservoir of replication-competent virus, FDCs may also alter the surrounding microenvironment to further support virus transmission.
The mechanism by which FDCs mediated increased CXCR4 levels on CD4 T cells has not been elucidated; however, data presented here indicate that the FDC effect was specific to CXCR4 expression because CD4 and CCR5 levels remained relatively unchanged (Fig. 1) . Examination of intracellular stores of CXCR4 did not reveal any differences between cultures with or without FDCs even though cell surface expression was increased when FDCs were present. One potential explanation for this observation is a decrease in the turnover rate of CXCR4 in the presence of FDCs, but this must be formally tested.
It appeared that the FDC-signaling that increased CXCR4 expression was mediated by a cell-bound and not a soluble molecule because FDC-T cell contact was necessary for modulation of CXCR4 by FDCs as evidenced by the failure to up-regulate the receptor when the FDCs were physically separated from the lymphocytes and because fixed FDCs were fully capable of inducing increased CXCR4 expression on CD4 T cells (Fig. 2C) . That the needed FDC-CD4 T cell contact can occur in vivo seems likely because Yuda et al. (46) showed that CD4 T cells in the light zone of secondary lymphoid follicles appear to be in direct contact with FDCs. This contact may facilitate both B and T cell contributions to GCs because FDCs provide both Ag-dependent and Ag-independent signals to lymphocytes that are believed to be important to induction of optimal T-dependent humoral immune responses (10, 16, 47, 48) . FDC-mediated up-regulation of CXCR4 on CD4 T cells is both Ag independent and primary as evidenced by the observation that both autologous (data not shown) and allogeneic FDCs ( Figs. 1 and 2 ) up-regulated this receptor equally well and that both unstimulated ( Figs. 1 and 2 ) and activated CD4 T cells underwent receptor up-regulation. Other FDC signals also function in an Ag-independent manner, including induction of B cell responsiveness to chemoattractants (also a primary signal), sparing of B lymphocytes from Fas-mediated apoptosis, and providing costimulatory signals to B lymphocytes (9, 10, 49) . These signals, as well as those mediated by FDC-retained Ags, are thought to be important for the optimal development of GCs and the maintenance of memory Ab responses (47, 50 -53) . Although the importance of B and T lymphocytes in the GC reaction is appreciated, the role of FDCs in lymphocyte recruitment into these sites is not well defined. However, it is known that FDCs produce chemoattractant signals for both B and T cells (54) and induce a state of chemotactic responsiveness in B cells (10) . Recently, a specialized Th cell, referred to as a follicular Th cell (T FH ), has been identified (55, 56) . These cells express CXCR5, and preferentially migrate to lymphoid follicles where they provide support for B cell differentiation (56 -58) . Kim et al. (41) recently observed that not all CXCR5 ϩ CD4 T cells are T FH but that CD57 ϩ CXCR5 ϩ tonsillar cells represent true T FH cells and preferentially migrate to B lymphocyte chemoattractant (CXCL13) which is found in the follicular mantle and on FDCs. In addition to expressing CXCR5, we found that CD4 ϩ CD57 ϩ GC T cells also express high levels of CXCR4 (Fig. 5C) ; however, the role of this latter chemokine receptor in T FH migration or in the GC reaction has not been elucidated. Further clarification is needed to understand follicular localization of CD4 ϩ lymphocytes and contributions of CXCR4, SDF-1␣, and FDCs in this process.
In addition to FDC contributions to CXCR4 up-regulation, other signals present in the GC microenvironment have been shown to influence CXCR4 expression. The Th2 cytokine IL-4 has been shown to increase CXCR4 expression while decreasing CCR5 on CD4 T cells (59 -62) . Interestingly, increased production of IL-4 has been demonstrated in HIV-1-infected individuals (59, (63) (64) (65) (66) (67) ; freshly isolated GC T cells (CD4 ϩ CD57 ϩ ) consistently express IL-4 mRNA, whereas non-CD57-bearing Th cells are often negative for IL-4 mRNA (38) . In addition to IL-4, TNF-␣, important in FDC development and function (68) , has also been shown to enhance CXCR4 expression on CD4 T cells (69) . Thus, the GC microenvironment contributed by both FDCs and lymphocytes appears to be ideally suited for augmenting CXCR4 expression and maintaining HIV infection.
Because HIV infection of CD4 T cells with either X4 or R5 strains likely depends on threshold concentrations of CD4 and coreceptors (70, 71) , FDCs and the GC microenvironment may be important in tropism shifts from R5 to X4 strains. Shortly after infection, most primary isolates from infected individuals use CCR5 as coreceptors even when the transmitting partner carries both R5-and X4-tropic viruses (72) . However, host factors that regulate HIV-1 coreceptors, may be important in infected individuals, because later in the course of disease viruses that use CXCR4 often evolve and become dominant. This adaptation to CXCR4 specificity in vivo accelerates HIV-1 disease progression (73) (74) (75) (76) . We reason that contributions from FDCs and the cytokine milieu present in the GC strongly favor CXCR4 expression on CD4 T cells and thus may be important over the course of disease in establishing an environment that favors the propagation of X4 virus quasi-species. In support of this reasoning, Berger et al (28) . hypothesized that HIV replication in specialized tissue compartments, which predominate in expression of a coreceptor, might select for viral variants. The data reported here do not demonstrate that virus tropism shifts occur in GCs, but they do provide evidence that relatively small differences in HIV coreceptor expression can influence viral infection in primary cells and suggest that this may contribute to selection of X4 variants over time. Because HIV is trapped on the FDC network early after infection and remains infectious for long periods of time (15, 42) , an understanding of the contributions of FDCs that lead to increased CXCR4 expression and heightened susceptibility to infection by X4 isolates of virus may be important to our ability to devise intervention strategies that effectively target this important HIV reservoir and microenvironment.
